Anne-Sophie Darrigade
Anne-Sophie Darrigade is an expert in Dermatology at Hôpital Saint-André (France). Anne-Sophie Darrigade has authored 97 publications, the most recent in 2024. SLR score: 236 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Immunology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2024
Number : 97
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Effect of Therapeutic Patient Education in Adults with Atopic Dermatitis: Analysis of Efficacy and Treatment Needs. PMID 39670437 — sexually transmitted diseases, quality of life, dermatitis, therapeutics, education, dermatology, patient education as topic, dermatitis, atopic | Acta Derm Venereol | 2024 | 0 |
| Atopic Dermatitis Activity Score 7 (ADAS7): A tool for disease activity assessment. PMID 39266939 — dermatitis, dermatitis, atopic | Clin Transl Allergy | 2024 | 0 |
| Impact of Atopic Dermatitis on Adult Women's Lives: A Survey of 1,009 French Women. PMID 38738770 — sexually transmitted diseases, dermatitis, eczema, dermatology, dermatitis, atopic | Acta Derm Venereol | 2024 | 8 |
| Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study. PMID 37871801 — dermatitis, allergic contact, dermatitis, atopic, allergens, therapeutics, dermatitis, contact, dermatology, patch tests | J Am Acad Dermatol | 2023 | 9 |
| Omalizumab Drug Survival in Chronic Urticaria: A Retrospective Multicentric French Study. PMID 37652349 — chronic urticaria, omalizumab, pharmaceutical preparations, hypersensitivity, urticaria, therapeutics | J Allergy Clin Immunol Pract | 2023 | 12 |
LeadR Networks
Main global connection map